Application 208800
- Type
- ANDA
- Sponsor
- TARO PHARM INDS LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DEFERIPRONE | DEFERIPRONE | TABLET;ORAL | 500MG | No | No |
| 002 | DEFERIPRONE | DEFERIPRONE | TABLET;ORAL | 1GM | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 51672-4196 | Deferiprone | Deferiprone | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-4196 | Deferiprone | Deferiprone | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-4196 | Deferiprone | Deferiprone | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-4196 | Deferiprone | Deferiprone | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-4196 | Deferiprone | Deferiprone | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 50739 | ORIG | 2019-03-12 |